Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
The Canadian Journal of Urology|June 13, 2015
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 casesNazneen Fatima, Daniel J Canter, Bradley C Carthon, et al.
Neuro-Oncology|May 28, 2015
Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastasesKirtesh R Patel, David H Lawson, Ragini R Kudchadkar, et al.
Frontiers in Oncology|December 18, 2025
Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibitionBrandon Wummer, Michael Schwartz, Jordan Ciuro, et al.
Clinical Genitourinary Cancer|February 7, 2018
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With NivolumabMehmet Asim Bilen, Giselle Marie Almeida Dutcher, Yuan Liu, et al.
Urologic Oncology|October 13, 2018
The addition of chemotherapy in the definitive management of high risk prostate cancerMatthew J Ferris, Yuan Liu, Jingning Ao, et al.
The Oncologist|December 24, 2025
Baseline geriatric 8 (G8) screening tool predicts overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitorsChristopher H Rhee, Subir Goyal, Yuan Liu, et al.
Cancers|June 24, 2022
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing TrialsTony Zibo Zhuang, Katherine Case, Timothy Anders Olsen, et al.
Frontiers in Oncology|December 19, 2022
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case reportTony Zibo Zhuang, Lara Harik, Seth Force, et al.
Frontiers in Endocrinology|April 8, 2022
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer ImmunotherapyT Anders Olsen, Tony Zibo Zhuang, Sarah Caulfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Pageof 6